While Voltas’ EMP revenues and overall profits were down, Blue Star did well and reported a turnaround at the net level, its third consecutive quarter of profits after it saw a loss in 2011-12. On the other hand, Voltas did well in UCP, while Blue Star’s lagged.
Going ahead, in the near-term challenges remain on account of weak demand. However, most analysts believe the economic growth and investment cycle will revive in FY14. And, given the reasonable valuations which reflect most of the negatives, investors could look at gradually accumulating the two stocks on declines.
Q3: Divergent trends
Between the two, Blue Star reported better performance than Voltas in the December 2012 quarter. With the EMP business reporting a nine-quarter high growth of 7.6%, Blue Star’s revenues grew, albeit marginally, by 2.6% year-on-year in the quarter. In contrast, Voltas’ EMP revenue declined 3.2% leading to flattish overall revenues.
For Voltas, EMP segment profit plunged 90% to Rs 6 crore thanks to the latter booking revenue of Sirda Medical project (85% complete) at zero margins. Although UCP segment profits were flat and Engineering Products and Service segment saw profits jump 55%, overall profits fell as EMP accounts for two-third of profits for Voltas.
Given that Blue Star’s order inflow (Rs 585 crore) in the quarter remained flat and order book (Rs 1,628 crore) declined around 25%, the prospects of EMP business aren’t exciting. Though Voltas has not announced these figures, analysts don’t expect the trend to be significantly different. They expect the challenges in EMP and UCP businesses to continue for some more time.
As regards UCP, generally, prices are revised in the March quarter just before the peak season (summer) starts. But, price hike hopes seem distant this time, as till date both companies have not announced any price hikes. Room AC industry went through one more quarter of de-growth (10%), notes Jain of Nirmal Bang. And besides sluggish demand, forex fluctuation could further impact margins.
Nevertheless, despite the grim outlook of the companies’ businesses, analysts are turning positive as they believe the worst is behind and valuation of about 10-11 times estimated FY14 earnings are reasonable.
Says Jain, “We think FY13 will be the year of all the concerns bottoming out and the revival of economy in FY14 can help Blue Star achieve similar growth as shown in previous up cycles. The focus on profitability and not volumes will also lead to better margin performance in FY14.”
Jain feels the poor demand environment leading to a poor performance by the company and corresponding decline in share price offers an opportunity to enter the stock, albeit with the a long term perspective. Adds Zarbade, “While the outlook (for Voltas) remains subdued, valuations are reasonable.”
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)